Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.035 | 0.8 |
mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.042 | 0.8 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.04 | 0.8 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.067 | 0.8 |
mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |